Successful delivery of chemotherapy to treat small-cell prostate cancer in a patient undergoing haemodialysis.
Affiliation
The Christie NHS Foundation Trust , Manchester , UKThe Christie NHS Foundation Trust , Manchester , UKIssue Date
2014-12
Metadata
Show full item recordAbstract
We report on the successful treatment of small-cell prostate cancer in a patient undergoing haemodialysis. The therapeutic regimen included 300 mg/m(2) of carboplatin and 50 mg/m(2) of etoposide coupled with radical radiotherapy. Adjustments to the patient's haemodialysis prescription included the use of high flux, a larger dialyser surface area and an increased dialysis time. The parameters used aided tolerance to the drug, allowing the delivery of safe, effective treatment. At an interval of over 12 months post-treatment the patient shows no clinical evidence of recurrent disease. This case provides evidence to encourage the use of chemotherapy in otherwise potentially undertreated haemodialysed patients.Citation
Successful delivery of chemotherapy to treat small-cell prostate cancer in a patient undergoing haemodialysis. 2014, 7 (6):593-4 Clin Kidney JJournal
Clinical Kidney JournalDOI
10.1093/ckj/sfu097PubMed ID
25859378Type
ArticleLanguage
enISSN
2048-8505ae974a485f413a2113503eed53cd6c53
10.1093/ckj/sfu097